Cargando…

OC.14.1 SARS-COV-2 INFECTION DOES NOT WORSEN THE COURSE OF INFLAMMATORY BOWEL DISEASE IN THE LONG TERM

Detalles Bibliográficos
Autores principales:	Neri, B., D'Agostini, G., Salvatori, S., Mossa, M., Bettin, F., Marafini, I., Lolli, E., Calabrese, E., Monteleone, G., Biancone, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2023
Materias:	Oral Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033227/ http://dx.doi.org/10.1016/S1590-8658(23)00320-1

Ejemplares similares

Low frequency of COVID-19 in inflammatory bowel diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy
por: Lolli, Elisabetta, et al.
Publicado: (2022)

Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
por: Scarozza, Patrizio, et al.
Publicado: (2020)

Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases
por: Salvatori, Silvia, et al.
Publicado: (2023)

OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
por: Di Grazia, A., et al.
Publicado: (2021)

Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case–Control Study
por: Neri, Benedetto, et al.
Publicado: (2023)

Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease
por: De Cristofaro, Elena, et al.
Publicado: (2023)

OC.06.3 POST-COVID-19 IRRITABLE BOWEL SYNDROME
por: Marasco, G., et al.
Publicado: (2023)

Natural History of Ulcerative Colitis with Coexistent Colonic Diverticulosis
por: Marafini, Irene, et al.
Publicado: (2021)

Long COVID in Inflammatory Bowel Diseases
por: Salvatori, Silvia, et al.
Publicado: (2021)

Long-Term Outcomes and Predictive Factors of Hospitalized Patients with Severe Ulcerative Colitis Treated with Intravenous Corticosteroids
por: De Cristofaro, Elena, et al.
Publicado: (2021)

OC.02.2 REDUCED EXPRESSION OF SARS-COV-2 INFECTION-RELATED GENES IN INFLAMMATORY BOWEL DISEASE PATIENTS
por: Pisani, L.F., et al.
Publicado: (2022)

OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS
por: Pelizzaro, F., et al.
Publicado: (2021)

OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
por: Todeschini, A., et al.
Publicado: (2022)

High Frequency of Undiagnosed Psychiatric Disorders in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY
por: Ferretti, F., et al.
Publicado: (2021)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

14.1 Clinical spectrum and outcome in 100 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2008)

Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters?
por: Marafini, Irene, et al.
Publicado: (2023)

OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY
por: Macaluso, F.S., et al.
Publicado: (2023)

Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn’s Disease
por: Zorzi, Francesca, et al.
Publicado: (2013)

A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study
por: Marafini, Irene, et al.
Publicado: (2021)

OC.05.6 HELICOBACTER PYLORI AND SARS-COV-2: A DANGEROUS PATHOGENETIC CORRELATION?
por: Termite, F., et al.
Publicado: (2023)

OC.02.9 IMPACT OF COVID-19 OUTBREAK ON GASTRO-INTESTINAL CANCER BURDEN
por: Milluzzo, S.M., et al.
Publicado: (2021)

Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders
por: Teofani, Adelaide, et al.
Publicado: (2022)

OC.06.9 ASSESSMENT OF SARCOPENIA AND NUTRITIONAL STATUS IN A COHORT OF PATIENTS WITH CROHN’S DISEASE
por: Nardone, O.M., et al.
Publicado: (2021)

OC.01.3 NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING HOSPITALIZATION DURING THE FIRST PHASE OF THE COVID-19 PANDEMIC IN VENETO REGION
por: Germana”, B., et al.
Publicado: (2021)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

OC.08.1 THE IMPACT OF THE COVID-19 PANDEMIC ON HOSPITALIZATIONS FOR DIVERTICULAR DISEASE
por: Germana’, B., et al.
Publicado: (2022)

Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab
por: De Cristofaro, Elena, et al.
Publicado: (2022)

Interleukin-34 promotes tumorigenic signals for colon cancer cells
por: Franzè, Eleonora, et al.
Publicado: (2021)

Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms
por: Salvatori, Silvia, et al.
Publicado: (2023)

Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek, Martin, et al.
Publicado: (2021)

Diagnostic yield of small bowel capsule endoscopy in obscure gastrointestinal bleeding: a real-world prospective study
por: Romeo, Samanta, et al.
Publicado: (2021)

OC.11.4 ITALIAN SOCIETY FOR DIGESTIVE DISEASES ACCREDITATION PROGRAM DURING COVID-19 PANDEMIC: RESULTS IN REMOTE REACCREDITATION IN 15 CENTRES
por: Spinzi, G., et al.
Publicado: (2023)

OC.07.2 FUNCTIONAL GASTROINTESTINAL AND SOMATOFORM SYMPTOMS FIVE MONTHS AFTER SARS-COV-2 INFECTION: A CONTROLLED COHORT STUDY
por: Noviello, D., et al.
Publicado: (2021)

OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
por: Guarino, M., et al.
Publicado: (2022)

OC-01 Venous thromboembolic events during the first and second waves of Covid-19 in breast cancer patients treated in an outpatient day hospital
por: Illarramendi, J., et al.
Publicado: (2021)

Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Marafini, Irene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvf97c5dci1lrhrpco50sergph